Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Zepbound GoodRx vs Savings Card vs LillyDirect: 2026 Prices
articleLilly runs two Zepbound savings cards, not one, and both carry the same $299 to $449 KwikPen dose ladder. This guide prices every route by eligibility class, names the device and dose behind each figure, and shows why GoodRx's $299 headline is the ladder's bottom rung.
Zepbound Savings Card: How to Get $25/Month (2026 Guide)
articlePrescribed Zepbound for weight management? This guide covers the savings card eligibility tiers, the exact per-fill and annual caps, how to enroll, why the card gets rejected at the pharmacy counter, and what to do if it does not apply to you.